Pyng Medical Signs Seven New Exclusive Specialty Distributors in the United States
Vancouver, B.C. (PRWEB) August 01, 2014 -- Pyng Medical Corp. (PYT:TSX.V), an award-winning developer of trauma and resuscitation products for emergency, combat, and critical care personnel, announces the signing of seven new exclusive medical device specialty distributors to market the company’s trauma products in the United States.
These new distributors already have exclusive rights to market Pyng Medical’s FASTResponder Sternal Intraosseous (IO) Device, and now also have exclusive rights to market Pyng’s T-PODResponder Pelvic Stabilization Device and MATResponder Tourniquet.
Both FASTResponder and T-PODResponder were recently recognized as Hot Products of 2014 by the Journal of Emergency Medical Services.
The new distributors will serve the USA hospital and pre-hospital markets within designated geographic regions. The Federal market segment will continue to be served by Bound Tree Medical.
“To support the launch of our new trauma products, we carefully selected distributors with proven success as well as extensive knowledge and territory relationships within the United States civilian Emergency Medical Services (EMS) and hospital acute-care markets,” explains Mark Hodge, CEO of Pyng Medical. “Each distributor already sells products that are complementary to Pyng’s product portfolio, and many of them have previous experience with Intraosseus Infusion.”
Mr. Hodge continues, “Signing these new distributors is a core element of Pyng’s FY14 business and growth strategy, and I am extremely confident we now have the right partnerships in place to not only market our current civilian products, but support our ongoing strategy which includes the launch of new products from our product development pipeline.”
The new specialty distributors are:
• Nightingale-Alan MES, LLC
• Sovereign Medical
• MED Alliance Group, Inc.
• Medical Specialties, Inc.
• Trail Ridge
• Healthcare Technology
• Medical Dynamics
For more details on each distributor, including the specific states and regions they cover within the United States, please visit http://go.pyng.com/distributor-search.
About Pyng Medical Corp.:
Pyng Medical Corp. engineers and markets award-winning trauma and resuscitation products for front-line critical care personnel worldwide. Pyng’s product portfolio includes innovative sternal intraosseous (sternal IO) pelvic stabilization and tourniquet devices specifically designed and customized for both the military and civilian markets. With growing markets in North America, Europe, and Asia, Pyng develops user-preferred medical devices for use by hospital staff, emergency medical services, and military forces worldwide.
More information about Pyng is available on SEDAR at http://www.sedar.com under the Company’s profile, and on its website: http://www.pyng.com.
For More Information:
George Dorin
Chief Financial Officer
Pyng Medical Corp.
(604) 303-7964 x219
http://www.pyng.com
Neither the TSX Venture Exchange nor its Regulatory Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Safe Harbour Statement; Forward-Looking Statements:
This release may contain forward-looking statements based on management's expectations, estimates, and projections. All statements that address expectations or projections about the future, including statements about the Company's strategy for growth, product development, market position, expected expenditures, and financial results are forward-looking statements: some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties, and assumptions. Many factors, including those discussed more fully elsewhere in this release and in documents which may be filed with the British Columbia Securities Commission, the Alberta Securities Commission, the TSX Venture Exchange, as well as other USA Commissions, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies, and economic conditions, including inflation, interest, and foreign currency exchange rates, of countries in which the Company does business; competitive pressures; successful integration of structural changes, including restructuring plans, acquisitions, divestitures, and alliances; cost of raw material, research, and development of new products, including regulatory approval and market acceptance; and seasonality of sales in some products.
Kim Moreau, Pyng Medical Corporation, http://go.pyng.com/distributor-search, +1 604-303-7964 Ext: 244, [email protected]
Share this article